Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on X:
“Precision isn’t just data; it’s safety! The FDA now recommends DPYD testing before starting Capecitabine or 5-FU. A small genetic trait can make these drugs toxic. Knowing this early saves lives.”

More posts featuring Yüksel Ürün on OncoDaily.